13F Data
13F filer · CIK 1911245

Northpond Ventures, LLC

Bethesda, MD · filing since Q4 2021 · last filing Nov 14, 2024
Reported value
$43.7M
$-11.6M vs prior
Positions
3
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $2.0M
Top-10 weight
100.0%

Biggest buys vs Q2 2024

No new or increased positions this quarter.

Biggest sells vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
Sold outTELESIS BIO INC-546,897-100.0%$-2.0M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $285.7MQ1 2022: $185.5MQ2 2022: $105.0MQ3 2022: $142.7MQ4 2022: $184.3MQ1 2023: $175.0MQ2 2023: $60.2MQ3 2023: $34.7MQ4 2023: $21.0MQ1 2024: $102.6MQ2 2024: $55.3MQ3 2024: $43.7M
Q4 2021Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1KYVERNA THERAPEUTICS INCCOM3,255,426$15.9M36.46%
2VIGIL NEUROSCIENCE INCCOM4,214,498$14.3M32.82%
3CANDEL THERAPEUTICS INCCOM1,935,215$13.4M30.72%